|
1
|
Parolin M, Parisotto M, Zanchetta F,
Sartorato P and De Menis E: Coronaviruses and endocrine system: A
systematic review on evidences and shadows. Endocr Metab Immune
Disord Drug Targets: Sep 5, 2020 (Epub ahead of print).
|
|
2
|
Sarkesh A, Daei Sorkhabi A, Sheykhsaran E,
Alinezhad F, Mohammadzadeh N, Hemmat N and Bannazadeh Baghi H:
Extrapulmonary clinical manifestations in COVID-19 patients. Am J
Trop Med Hyg. 103:1783–1796. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Young MJ, Clyne CD and Chapman KE:
Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and
SARS-CoV-2. J Endocrinol. 247:R45–R62. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Caricchio R, Gallucci M, Dass C, Zhang X,
Gallucci S, Fleece D, Bromberg M and Criner GJ: Temple University
COVID-19 Research Group. Preliminary predictive criteria for
COVID-19 cytokine storm. Ann Rheum Dis. 80:88–95. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Shamsoddin E: Can medical practitioners
rely on prediction models for COVID-19? A systematic review. Evid
Based Dent. 21:84–86. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kruglikov IL, Shah M and Scherer PE:
Obesity and diabetes as comorbidities for COVID-19: Underlying
mechanisms and the role of viral-bacterial interactions. Elife.
9(e61330)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
John JE and John NA: Imminent risk of
COVID-19 in diabetes mellitus and undiagnosed diabetes mellitus
patients. Pan Afr Med J. 36(158)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kwok S, Adam S, Ho JH, Iqbal Z, Turkington
P, Razvi S, Le Roux CW, Soran H and Syed AA: Obesity: A critical
risk factor in the COVID-19 pandemic. Clin Obes.
10(e12403)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Caron P: Thyroid disorders and SARS-CoV-2
infection: From pathophysiological mechanism to patient management.
Ann Endocrinol (Paris). 81:507–510. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Gorini F, Bianchi F and Iervasi G:
COVID-19 and thyroid: Progress and prospects. Int J Environ Res
Public Health. 17(6630)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gavriatopoulou M, Korompoki E, Fotiou D,
Ntanasis-Stathopoulos I, Psaltopoulou T, Kastritis E, Terpos E and
Dimopoulos MA: Organ-specific manifestations of COVID-19 infection.
Clin Exp Med. 20:493–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lazartigues E, Qadir MMF and
Mauvais-Jarvis F: Endocrine significance of SARS-CoV-2's reliance
on ACE2. Endocrinology. 161(bqaa108)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Marazuela M, Giustina A and Puig-Domingo
M: Endocrine and metabolic aspects of the COVID-19 pandemic. Rev
Endocr Metab Disord. 21:495–507. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chen M, Zhou W and Xu W: Thyroid function
analysis in 50 patients with COVID-19: A retrospective study.
Thyroid. 31:8–11. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cocolos AM, Dumitru N, Petrova EN, Cocolos
I, Tiglis M, Dragomirescu RFI, Olaru M, Dumitru A and Ghemigian AM:
Endocrine disrupting chemicals-the X factor in different
pathologies. Rev Chim (Bucharest). 69:136–139. 2018.
|
|
16
|
Davis PJ, Lin HY, Hercbergs A, Keating KA
and Mousa SA: Coronaviruses and integrin αvβ3: Does thyroid hormone
modify the relationship? Endocr Res. 45:210–215. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Pantos C, Kostopanagiotou G, Armaganidis
A, Trikas A, Tseti I and Mourouzis I: Triiodothyronine for the
treatment of critically ill patients with COVID-19 infection: A
structured summary of a study protocol for a randomised controlled
trial. Trials. 21(573)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Muller I, Cannavaro D, Dazzi D, Covelli D,
Mantovani G, Muscatello A, Ferrante E, Orsi E, Resi V, Longari V,
et al: SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes
Endocrinol. 8:739–741. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Mattar SAM, Koh SJQ, Rama Chandran S and
Cherng BPZ: Subacute thyroiditis associated with COVID-19. BMJ Case
Rep. 13(e237336)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Brancatella A, Ricci D, Cappellani D,
Viola N, Sgrò D, Santini F and Latrofa F: Is subacute thyroiditis
an underestimated manifestation of SARS-CoV-2 infection? Insights
from a case series. J Clin Endocrinol Metab.
105(dgaa537)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Asfuroglu Kalkan E and Ates I: A case of
subacute thyroiditis associated with Covid-19 infection. J
Endocrinol Invest. 43:1173–1174. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ippolito S, Dentali F and Tanda ML:
SARS-CoV-2: A potential trigger for subacute thyroiditis? Insights
from a case report. J Endocrinol Invest. 43:1171–1172.
2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Brancatella A, Ricci D, Viola N, Sgrò D,
Santini F and Latrofa F: Subacute thyroiditis after Sars-COV-2
infection. J Clin Endocr Metab. 105(dgaa276)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bellastella G, Maiorino MI and Esposito K:
Endocrine complications of COVID-19: What happens to the thyroid
and adrenal glands? J Endocrinol Invest. 43:1169–1170.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bordallo B, Bellas M, Cortez AF, Vieira M
and Pinheiro M: Severe COVID-19: What have we learned with the
immunopathogenesis? Adv Rheumatol. 60(50)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lania A, Sandri MT, Cellini M, Mirani M,
Lavezzi E and Mazziotti G: Thyrotoxicosis in patients with
COVID-19: The THYRCOV study. Eur J Endocrinol. 183:381–387.
2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Liu Z, Li J, Chen D, Gao R, Zeng W, Chen
S, Huang Y, Huang J, Long W, Li M, et al: Dynamic interleukin-6
level changes as a prognostic indicator in patients with COVID-19.
Front Pharmacol. 11(1093)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Pal R: COVID-19,
hypothalamo-pituitary-adrenal axis and clinical implications.
Endocrine. 68:251–252. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gaman MA, Dobrica EC, Pascu EG, Cozma MA,
Epingeac ME, Gaman AM, Pantea Stoian A, Bratu OG and Diaconu CC:
Cardio metabolic risk factors for atrial fibrillation intype 2
diabetes mellitus: Focus on hypertension,metabolic syndrome and
obesity. J Mind Med Sci. 6:157–161. 2019.
|
|
30
|
Djakpo DK, Wang Z, Zhang R, Chen X, Chen P
and Antoine MM: Blood routine test in mild and common 2019
coronavirus (COVID-19) patients. Biosci Rep.
40(BSR20200817)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kahaly GJ: Management of graves thyroidal
and extrathyroidal disease: An update. J Clin Endocrinol Metab.
105:3704–3720. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Shams PN: High-dose oral
methylprednisolone for the management of severe active thyroid eye
disease during the coronavirus disease 2019 pandemic. Ophthalmic
Plast Reconstr Surg. 36:418–419. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kaiser UB, Mirmira RG and Stewart PM: Our
response to COVID-19 as endocrinologists and diabetologists. J Clin
Endocrinol Metab. 105(dgaa148)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Isidori AM, Pofi R, Hasenmajer V, Lenzi A
and Pivonello R: Use of glucocorticoids in patients with adrenal
insufficiency and COVID-19 infection. Lancet Diabetes Endocrinol.
8:472–473. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Blevins T and Ozer K: Telemedicine during
the COVID-19 crisis and beyond. Tex Med. 116:4–5. 2020.PubMed/NCBI
|
|
36
|
Pal R and Banerjee M: COVID-19 and the
endocrine system: Exploring the unexplored. J Endocrinol Invest.
43:1027–1031. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Boelaert K, Visser WE, Taylor PN, Moran C,
Léger J and Persani L: Endocrinology in the time of COVID-19:
Management of hyperthyroidism and hypothyroidism. Eur J Endocrinol.
183:G33–G39. 2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Velayoudom FL, Alwis Wijewickrama PS,
Ranathunga HI and Somasundaram N: Endocrine vigilance in COVID-19.
J Pak Med Assoc. 70 (Suppl 3):S83–S86. 2020.PubMed/NCBI View
Article : Google Scholar
|
|
39
|
Poiana C, Chirita C, Carsote M, Hortopan D
and Goldstein A: Galactocele and prolactinoma-a pathogenic
association? Maturitas. 62:98–102. 2009.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Sandru F, Carsote M, Albu SE, Valea A,
Petca A and Dumitrascu MC: Glucagonoma: From skin lesions to the
neuroendocrine component (Review). Exp Ther Med. 20:3389–3393.
2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Kumar A, Arora A, Sharma P, Anikhindi SA,
Bansal N, Singla V, Khare S and Srivastava A: Clinical features of
COVID-19 and factors associated with severe clinical course: A
systematic review and meta-analysis. SSRN: 3566166, 2020.
|
|
42
|
Diaconu C: Treatment of diabetes in
patients with heart failure. In: The 3rd International Conference
on Interdisciplinary Management of Diabetes Mellitus and its
Complications-Diabetes Mellitus in Internal Medicine, INTERDIAB
2017 Proceedings. Serafinceanu C, Negoita O and Elian V (eds).
Niculescu, Bucharest, pp170-177, 2017.
|
|
43
|
Al Hayek AA, Robert AA, Alotaibi ZK and Al
Dawish M: Clinical characteristics of hospitalized and home
isolated COVID-19 patients with type 1 diabetes. Diabetes Metab
Syndr. 14:1841–1845. 2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Iughetti L, Trevisani V, Cattini U, Bruzzi
P, Lucaccioni L, Madeo S and Predieri B: COVID-19 and type 1
diabetes: Concerns and challenges. Acta Biomed.
91(e2020033)2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Kalra S and Mittal S: COVID-19 and
diabetes: Covidiabetology. J Pak Med Assoc. 70:954–955.
2020.PubMed/NCBI
|
|
46
|
Isidori AM, Arnaldi G, Boscaro M, Falorni
A, Giordano C, Giordano R, Pivonello R, Pofi R, Hasenmajer V,
Venneri MA, et al: COVID-19 infection and glucocorticoids: Update
from the Italian society of endocrinology expert opinion on steroid
replacement in adrenal insufficiency. J Endocrinol Invest.
43:1141–1147. 2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Radu L, Carsote M, Gheorghisan-Galateanu
AA, Preda SA, Calborean V, Stanescu R, Gheorman V and Albulescu DM:
Blood parathyrin and mineral metabolism dynamics. A clinical
analyze. Rev Chim (Bucharest). 69:2754–2758. 2018.
|
|
48
|
Albulescu DM, Carsote M, Ghemigian A,
Popescu M, Predescu AM, Tuculina MJ, Bugala AS, Bataiosu M,
Marinescu RI, Dascalu IT, et al: Circulating
25-hydroxycholecalciferool in relationship to central dual-energy
X-Ray absorptiometry assesses. A clinical study. Rev Chim
(Bucharest). 69:3683–3687. 2018.
|
|
49
|
Carsote M, Preda SA, Mitroi M, Camen A and
Radu L: Serum osteocalcin, P1NP, alkaline phosphase, and crosslaps
in humans: The relationship with body mass index. Rev Chim
(Bucharest). 70:1615–1618. 2019.
|
|
50
|
Teymoori-Rad M and Marashi SM: Vitamin D
and Covid-19: From potential therapeutic effects to unanswered
questions. Rev Med Virol. 31(e2159)2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Smulever A, Abelleira E, Bueno F and
Pitoia F: Thyroid cancer in the era of COVID-19. Endocrine. 70:1–5.
2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Klain M, Nappi C, Maurea S, De Risi M,
Volpe F, Caiazzo E, Piscopo L, Manganelli M, Schlumberger M and
Cuocolo A: Management of differentiated thyroid cancer through
nuclear medicine facilities during Covid-19 emergency: The
telemedicine challenge. Eur J Nucl Med Mol Imaging: Sep 23, 2020
(Epub ahead of print).
|
|
53
|
Vrachimis A, Iakovou I, Giannoula E and
Giovanella L: Endocrinology in the time of COVID-19: Management of
thyroid nodules and cancer. Eur J Endocrinol. 183:G41–G48.
2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Zhang D, Fu Y, Zhou L, Liang N, Wang T,
Del Rio P, Rausei S, Boni L, Park D, Jafari J, et al: Thyroid
surgery during coronavirus-19 pandemic phases I, II and III:
Lessons learned in China, South Korea, Iran and Italy. J Endocrinol
Invest: Sep 2, 2020 (Epub ahead of print).
|
|
55
|
Facchiano A, Facchiano F and Facchiano A:
An investigation into the molecular basis of cancer comorbidities
in coronavirus infection. FEBS Open Bio. 10:2363–2374.
2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Buruiana A, Dumitru N, Ghemigian A and
Petrova EN: Genetic testing in differentiated thyroid
carcinoma-important or not? Rev Chim (Bucharest). 68:1557–1559.
2017.
|
|
57
|
Docea AO, Tsatsakis A, Albulescu D,
Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou
M, Drakoulis N, et al: A new threat from an old enemy: Re-emergence
of coronavirus (Review). Int J Mol Med. 45:1631–1643.
2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Calina D, Docea AO, Petrakis D, Egorov AM,
Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Carvalho F,
Vinceti M, et al: Towards effective COVID-19 vaccines: Updates,
perspectives and challenges (Review). Int J Mol Med. 46:3–16.
2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Montesinos MDM and Pellizas CG: Thyroid
hormone action on innate immunity. Front Endocrinol (Lausanne).
10(350)2019.PubMed/NCBI View Article : Google Scholar
|
